Successful treatment of severe gastrointestinal bleeding secondary to Crohn disease with recombinant factor VIIa

Southern Medical Journal

Volumn 100, Issue 6, 2007, Pages 601-604

  Girona, Eva ^b   Borrás Blasco, Joaquín ^a   Conesa García, Venancio ^b   Navarro Ruiz, Andrés ^b   Solís, Javier ^b   García Sepulcre, Mariana Fe ^b   Oliver García, Israel ^b  

^a HOSPITAL DE SAGUNTO   (Spain)

^b NONE

Author keywords

Bleeding; Crohn disease; Hemorrhage; Recombinant factor VIIa; Surgery

Indexed keywords

METHYLPREDNISOLONE; METRONIDAZOLE; OMEPRAZOLE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; COLONOSCOPY; CROHN DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPOVOLEMIC SHOCK; MALE; RECTUM ULCER;

CROHN DISEASE; FACTOR VII; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 34250712257     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31804859a4     Document Type: Article

References (19)

1. Robert JR, Sachar DB, Greenstein AJ, et al. Severe gastrointestinal hemorrhage in Crohn's disease. Ann Surg 1991;213:207-211.
2. Driver CP, Anderson DN, Keenan RA, et al. Massive intestinal bleeding in association with Crohn's disease. J R Coll Surg Edinb 1996;41:152-154.
3. Belaiche J, Louis E, D'Haens G, et al. Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Am J Gastroenterol 1999;94:2177-2181.
4. Veroux M, Angriman I, Ruffolo C, et al. Severe gastrointestinal bleeding in Crohn's disease. Ann Ital Chir 2003;74:213-215.
5. Keuchel M, Hagenmuller F. Small bowel endoscopy. Endoscopy 2005;37:122-132.
6. Vlot AJ, Ton E, Mackaay AJC, et al. Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII. Am J Med 2000;108:421-423.
7. Ejlersen E, Melsen T, Ingerslev J, et al. Recombinant activated factor VII (rFVIIa) acutely normalized prothrombin time in patients with cirrhosis during bleeding from esophageal varices. Scand J Gastroenterol 2001;36:1081-1085.
8. Romero-Castro R, Jimenez-Saenz M, Pellicer-Bautista F, et al. Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices. Clin Gastroenterol Hepatol 2004;2:78-84.
9. Jurlander B, Thim L, Klausen NK, et al. Recombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical development. Semin Thromb Hemost 2001;27:373-384.
10. Lisman T, Adelmeijer J, Heijnen HF, et al. Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factorindependent fibrin generation. Blood 2004;103:1720-1727.
11. Conesa V, Navarro-Ruiz A, Borrás-Blasco J, et al. Recombinant factor VIIa is an effective therapy for abdominal surgery and severe thrombocytopenia: a case report. Int J Hematol 2005;81:75-76.
12. Borrás-Blasco J, Conesa-Garcia V, Navarro-Ruiz A, et al. Use of recombinant factor VIIa for life-threatening bleeding in a patient with severe necrotizing pancreatitis. Pancreas 2005;31:292-294.
13. Lam MS, Sims-McCallum RP. Recombinant factor VIIa in the treatment of non-hemophiliac bleeding. Ann Pharmacother 2005;39:885-891.
14. White B, McHale J, Ravi N, et al. Successful use of recombinant FVIIa (Novoseven) in the management of intractable post-surgical intra-abdominal haemorrhage. Br J Haematol 1999:107;677-678.
15. O'Connell KA, Wood JJ, Wise RP, et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 2006;295:293-298.
16. Friederich PW, Henny CP, Messelink EJ, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 2003;361:201-205.
17. Goodnough LT, Hewitt PE, Silliman CC. Transfusion medicine: joint ASH and AABB educational session. Am Soc Hematol Educ Program 2004;457-472.
18. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomised, placebo-controlled, double-blind clinical trials. J Trauma 2005;59:8-15.
19. Erhardtsen E. Pharmacokinetics of recombinant activated factor VII (rFVIIa). Semin Thromb Hemost 2000;26:385-391.